Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.27B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.25B |
| 3 |
Oracle
ORCL
|
+$1.09B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.06B |
| 5 |
JPMorgan Chase
JPM
|
+$953M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$2.08B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Thermo Fisher Scientific
TMO
|
+$1.12B |
| 4 |
Qualcomm
QCOM
|
+$1.05B |
| 5 |
Mastercard
MA
|
+$877M |
Sector Composition
| 1 | Technology | 29.55% |
| 2 | Healthcare | 13.79% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Financials | 10.34% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Brunswick
BC
$4.32B
| $124M | 0.01% |
1,428,779
+759,646
| +114% | +$65.8M |
|
902
Kirby Corp
KEX
$4.91B
| $123M | 0.01% |
1,604,527
-185,935
| -10% | -$14.3M |
|
903
iShares MSCI USA Momentum Factor ETF
MTUM
$18.9B
| $123M | 0.01% |
853,490
-1,549,651
| -64% | -$224M |
|
904
Immunocore
IMCR
$1.82B
| $123M | 0.01% |
2,046,107
-43,444
| -2% | -$2.6M |
|
905
Carvana
CVNA
$49.4B
| $121M | 0.01% |
4,671,950
+4,687
| +0.1% | +$121K |
|
906
Akero Therapeutics
AKRO
$3.52B
| $121M | 0.01% |
2,587,528
+1,446,243
| +127% | +$67.5M |
|
907
Norfolk Southern
NSC
$61.6B
| $121M | 0.01% |
531,564
+142,746
| +37% | +$32.4M |
|
908
UFP Industries
UFPI
$5.98B
| $120M | 0.01% |
1,237,202
+53,553
| +5% | +$5.2M |
|
|
SUM
909
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $120M | 0.01% |
3,166,552
-1,538,785
| -33% | -$58.2M |
|
910
Onto Innovation
ONTO
$5.36B
| $120M | 0.01% |
1,028,588
+29,378
| +3% | +$3.42M |
|
911
Novartis
NVS
$247B
| $120M | 0.01% |
1,185,320
+76,113
| +7% | +$7.68M |
|
912
iShares Short Maturity Bond ETF
NEAR
$3.55B
| $119M | 0.01% |
2,393,748
+304,243
| +15% | +$15.1M |
|
|
EDR
913
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $119M | 0.01% |
4,961,671
-1,229,289
| -20% | -$29.4M |
|
914
DiamondRock Hospitality
DRH
$1.72B
| $118M | 0.01% |
14,763,264
+440,659
| +3% | +$3.53M |
|
915
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.68B
| $118M | 0.01% |
2,146,295
+343,269
| +19% | +$18.9M |
|
916
Avidity Biosciences
RNA
$4.76B
| $118M | 0.01% |
10,622,864
+5,203,807
| +96% | +$57.7M |
|
917
Leidos
LDOS
$23.6B
| $118M | 0.01% |
1,328,760
+335,651
| +34% | +$29.7M |
|
918
CRISPR Therapeutics
CRSP
$4.92B
| $117M | 0.01% |
2,091,173
-47,883
| -2% | -$2.69M |
|
919
General Mills
GIS
$27B
| $117M | 0.01% |
1,527,852
+160,215
| +12% | +$12.3M |
|
920
Adtalem Global Education
ATGE
$4.9B
| $117M | 0.01% |
3,407,599
-1,524,209
| -31% | -$52.3M |
|
921
Biomea Fusion
BMEA
$113M
| $117M | 0.01% |
5,310,165
+2,637,143
| +99% | +$57.9M |
|
922
Blackbaud
BLKB
$3.34B
| $117M | 0.01% |
1,637,307
-83,966
| -5% | -$5.98M |
|
923
Grupo Aeroportuario del Sureste
ASR
$10.3B
| $116M | 0.01% |
418,537
+9,225
| +2% | +$2.56M |
|
924
Olaplex Holdings
OLPX
$954M
| $116M | 0.01% |
31,054,602
-7,659,953
| -20% | -$28.5M |
|
|
HCP
925
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $115M | 0.01% |
4,402,241
+2,717,837
| +161% | +$71.2M |
|